Abstract shapes animated in a loop.
Professor Swen Hoelder
Meet Swen, a co-investigator on PROTECT
Professor Swen Hoelder is a medicinal chemist working to discover novel cancer drugs. His recent achievements include the discovery of the MPS1 inhibitor and the clinical candidate BOS172722, which entered Phase 1 clinical development for triple negative breast cancer.
Swen has experience in the pharmaceutical industry, with positions in Hoechst Marion Roussel (now Sanofi) and Altana (now Takeda), where he led a team of chemists that discovered two pre-clinical candidates for cancer. Swen joined the ICR in 2007 and is now the Head of Chemistry within the Centre for Cancer Drug Discovery, at The Institute of Cancer Research, London.